Novo Nordisk Looks to Target Hair Loss in Consumer Push
The maker of Ozempic and Wegovy seeks to expand its direct-to-consumer pharmaceutical business as rival Eli Lilly outpaces in weight-loss drugs.
Beauty
Analysis and advice on the fast-evolving beauty business.
Remedy Place Will Open New SoHo Location
The “luxury social wellness club” is expanding in response to growing consumer demand for self-care treatments.
Beauty’s Olympics Marketing Playbook
Beauty brands may not have their logo on an athlete’s uniform, but they’re still finding ways to market around the Olympics through partnerships with top athletes and social-media friendly campaigns.
The Business of Beauty Haul of Fame: Why Brands Are Roasting Their Customers
Tough love is making some shoppers hit “add to cart.”
The Soho House of Nail Salons
Majesty’s Pleasure, which opened this week in New York City, wants to offer nail services and eventually, other beauty offerings to a clientele that wants a social outlet as much as they do a fresh manicure.
The Wellness Brand Betting on ‘Female Viagra’
Sex wellness company Hello Cake is tackling the oft-neglected category of female sexual health, hoping to position itself as a leader in the pleasure category.
Isamaya Ffrench on the Spirit of Collaboration
For two decades, fashion has proved how powerful the right link-up between brands can be. Why hasn’t beauty done the same?
How Clarins Is Reformulating Its Hero Product (And Its Business)
The French skincare giant is launching the ninth generation of its flagship Double Serum line, while achieving record financial results.
The Business of Beauty Haul of Fame: Exclusive - Camila Mendes Is Really Good for Skincare
Fiscal proof that celebrity alliances work (if the product also works).
Summer Fridays Announces Growth Investment From TSG Consumer Partners
The influencer-founded beauty brand, known for its hybrid skincare and makeup products, will join private equity firm TSG’s brand roster.
Exclusive: Sabrina Carpenter’s Plan to Become a Beauty Hitmaker
With the launch of her third fragrance, Cherry Baby, the “Espresso” songstress wants to use the whimsical, flirty scent to connect more deeply with her growing fanbase of Gen-Zers and beyond.
Male Infertility Anxiety Is Driving the Latest Wellness Boom
Male wellness products have long been centred around muscle building, endurance and other athletic pursuits. Now, brands and consumers are switching their focus to virility, fertility and sexual peak performance.
Indian Fashion Designers Wade Into Beauty
Well-known designers like Manish Malhotra and Sabyasachi Mukherjee are hoping that their reputation in luxury fashion circles will help bring them success in the highly competitive and price-sensitive beauty market.
THE NEWS IN BRIEF
PR Agency CGC Launches Performance Media Division
Known for its premium beauty clients including Glossier and Hermès Beauty, the agency’s new division combines influencer marketing and AI insights.
Luxury Perfume Line Roja London Acquired by Extravaganza Beauty
Master perfumer and founder Roja Dove will remain with the brand in a new consultancy role.
Olaplex Names New CEO
Christoph Kaul will succeed Amanda Baldwin, who led the hair care label through its acquisition by Henkel earlier this year.
Perelel Expands C-Suite, Tapping Rare Beauty’s CMO
Known for its prenatal vitamins, the wellness label has hired Rare Beauty's Ashley Murphy as its chief marketing officer, while Anjelika Temple moves into the chief creative officer role.
Supergoop Announces Chief Commercial Officer
The sunscreen label has appointed former Coty executive Jamie Parker to the newly created role as it gears up to become a “global skin health company.”
L’Oréal Steals French Stock Market Crown From LVMH
The cosmetics group became France’s most valuable listed company on Tuesday, the first time since 2017 that a non-luxury company has claimed the top spot at the end of a trading day.
Kimberly-Clark Prepares Asset Sales to Win EU Nod for Kenvue Deal
The US consumer goods giant is preparing concessions to address EU antitrust concerns about its bid for Tylenol maker Kenvue that could help it win approval for the $40 billion deal, sources told Reuters.